nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—SLC29A1—Pemetrexed—lung cancer	0.255	0.509	CbGbCtD
Dipyridamole—SLC29A1—Gemcitabine—lung cancer	0.0918	0.183	CbGbCtD
Dipyridamole—ABCB1—lung cancer	0.0851	1	CbGaD
Dipyridamole—ABCC5—Cisplatin—lung cancer	0.051	0.102	CbGbCtD
Dipyridamole—ABCC4—Methotrexate—lung cancer	0.0159	0.0317	CbGbCtD
Dipyridamole—ABCB1—Topotecan—lung cancer	0.0119	0.0238	CbGbCtD
Dipyridamole—ADA—pleura—lung cancer	0.0116	0.134	CbGeAlD
Dipyridamole—ABCB1—Gefitinib—lung cancer	0.0109	0.0218	CbGbCtD
Dipyridamole—ABCB1—Vinorelbine—lung cancer	0.0084	0.0168	CbGbCtD
Dipyridamole—ABCB1—Crizotinib—lung cancer	0.00669	0.0133	CbGbCtD
Dipyridamole—ABCB1—Gemcitabine—lung cancer	0.00654	0.013	CbGbCtD
Dipyridamole—ABCB1—Erlotinib—lung cancer	0.00645	0.0129	CbGbCtD
Dipyridamole—ABCB1—Paclitaxel—lung cancer	0.0059	0.0118	CbGbCtD
Dipyridamole—ABCB1—Irinotecan—lung cancer	0.00582	0.0116	CbGbCtD
Dipyridamole—PDE5A—pulmonary artery—lung cancer	0.0057	0.0654	CbGeAlD
Dipyridamole—ABCB1—Vinblastine—lung cancer	0.00518	0.0103	CbGbCtD
Dipyridamole—ABCB1—Cisplatin—lung cancer	0.00475	0.00947	CbGbCtD
Dipyridamole—ABCB1—Etoposide—lung cancer	0.00467	0.00931	CbGbCtD
Dipyridamole—ABCB1—Docetaxel—lung cancer	0.00427	0.00851	CbGbCtD
Dipyridamole—ABCB1—Doxorubicin—lung cancer	0.00318	0.00635	CbGbCtD
Dipyridamole—ABCB1—Methotrexate—lung cancer	0.00308	0.00615	CbGbCtD
Dipyridamole—PDE6B—respiratory system—lung cancer	0.00271	0.0311	CbGeAlD
Dipyridamole—PDE2A—mammary gland—lung cancer	0.00246	0.0282	CbGeAlD
Dipyridamole—PRUNE—bronchus—lung cancer	0.00235	0.0269	CbGeAlD
Dipyridamole—PDE6D—bronchus—lung cancer	0.00227	0.026	CbGeAlD
Dipyridamole—PDE8A—mammary gland—lung cancer	0.00211	0.0242	CbGeAlD
Dipyridamole—PDE11A—epithelium—lung cancer	0.00211	0.0242	CbGeAlD
Dipyridamole—PRUNE—cardiac atrium—lung cancer	0.00198	0.0227	CbGeAlD
Dipyridamole—PDE4A—mammary gland—lung cancer	0.00169	0.0194	CbGeAlD
Dipyridamole—PDE1C—lung—lung cancer	0.00168	0.0193	CbGeAlD
Dipyridamole—PDE10A—respiratory system—lung cancer	0.00164	0.0188	CbGeAlD
Dipyridamole—PDE6D—bone marrow—lung cancer	0.00161	0.0185	CbGeAlD
Dipyridamole—PRUNE—lung—lung cancer	0.00151	0.0174	CbGeAlD
Dipyridamole—PDE6D—lung—lung cancer	0.00146	0.0168	CbGeAlD
Dipyridamole—PDE6B—lung—lung cancer	0.00144	0.0165	CbGeAlD
Dipyridamole—ABCC5—mammary gland—lung cancer	0.00132	0.0151	CbGeAlD
Dipyridamole—PDE6G—lung—lung cancer	0.00129	0.0148	CbGeAlD
Dipyridamole—PDE8B—bronchus—lung cancer	0.00129	0.0148	CbGeAlD
Dipyridamole—PDE2A—trachea—lung cancer	0.00121	0.0139	CbGeAlD
Dipyridamole—SLC29A1—mammary gland—lung cancer	0.00121	0.0139	CbGeAlD
Dipyridamole—PDE8A—bronchus—lung cancer	0.00116	0.0133	CbGeAlD
Dipyridamole—ADA—respiratory system—lung cancer	0.00116	0.0133	CbGeAlD
Dipyridamole—PRUNE—Podofilox—Teniposide—lung cancer	0.00115	0.26	CbGdCrCtD
Dipyridamole—PDE1C—lymph node—lung cancer	0.00115	0.0132	CbGeAlD
Dipyridamole—PDE2A—cardiac atrium—lung cancer	0.00114	0.0131	CbGeAlD
Dipyridamole—PDE7B—lung—lung cancer	0.00104	0.012	CbGeAlD
Dipyridamole—PDE8A—trachea—lung cancer	0.00104	0.0119	CbGeAlD
Dipyridamole—PRUNE—lymph node—lung cancer	0.00104	0.0119	CbGeAlD
Dipyridamole—PDE6D—lymph node—lung cancer	0.001	0.0115	CbGeAlD
Dipyridamole—PDE8A—cardiac atrium—lung cancer	0.000976	0.0112	CbGeAlD
Dipyridamole—PDE5A—respiratory system—lung cancer	0.000958	0.011	CbGeAlD
Dipyridamole—PDE3B—bone marrow—lung cancer	0.000894	0.0103	CbGeAlD
Dipyridamole—PDE6G—lymph node—lung cancer	0.000881	0.0101	CbGeAlD
Dipyridamole—PDE2A—lung—lung cancer	0.00087	0.00998	CbGeAlD
Dipyridamole—PDE10A—lung—lung cancer	0.00087	0.00998	CbGeAlD
Dipyridamole—PDE8B—lung—lung cancer	0.00083	0.00952	CbGeAlD
Dipyridamole—PDE3B—lung—lung cancer	0.00081	0.0093	CbGeAlD
Dipyridamole—SLC29A1—respiratory system—lung cancer	0.000805	0.00924	CbGeAlD
Dipyridamole—PDE5A—epithelium—lung cancer	0.000801	0.00919	CbGeAlD
Dipyridamole—PDE8A—lung—lung cancer	0.000746	0.00857	CbGeAlD
Dipyridamole—PRUNE—Vincristine—Vinorelbine—lung cancer	0.000732	0.165	CbGdCrCtD
Dipyridamole—PDE1A—lung—lung cancer	0.000722	0.00829	CbGeAlD
Dipyridamole—ABCC5—bronchus—lung cancer	0.000721	0.00828	CbGeAlD
Dipyridamole—PDE7B—lymph node—lung cancer	0.000713	0.00818	CbGeAlD
Dipyridamole—PRUNE—Vinorelbine—Vinblastine—lung cancer	0.000684	0.155	CbGdCrCtD
Dipyridamole—PRUNE—Podofilox—Etoposide—lung cancer	0.000684	0.155	CbGdCrCtD
Dipyridamole—ADA—bone marrow—lung cancer	0.000678	0.00778	CbGeAlD
Dipyridamole—SLC29A1—bronchus—lung cancer	0.000662	0.0076	CbGeAlD
Dipyridamole—PDE3A—cardiac atrium—lung cancer	0.000647	0.00743	CbGeAlD
Dipyridamole—ADA—lung—lung cancer	0.000614	0.00705	CbGeAlD
Dipyridamole—ABCC5—cardiac atrium—lung cancer	0.000609	0.00699	CbGeAlD
Dipyridamole—PDE4A—lung—lung cancer	0.000598	0.00687	CbGeAlD
Dipyridamole—PDE2A—lymph node—lung cancer	0.000595	0.00683	CbGeAlD
Dipyridamole—PDE10A—lymph node—lung cancer	0.000595	0.00683	CbGeAlD
Dipyridamole—SLC29A1—trachea—lung cancer	0.000595	0.00683	CbGeAlD
Dipyridamole—PDE1B—lymph node—lung cancer	0.000589	0.00677	CbGeAlD
Dipyridamole—PRUNE—Vinblastine—Vinorelbine—lung cancer	0.000589	0.133	CbGdCrCtD
Dipyridamole—PRUNE—Vincristine—Vinblastine—lung cancer	0.000585	0.132	CbGdCrCtD
Dipyridamole—PDE8B—lymph node—lung cancer	0.000567	0.00651	CbGeAlD
Dipyridamole—SLC29A1—cardiac atrium—lung cancer	0.000559	0.00641	CbGeAlD
Dipyridamole—PDE3B—lymph node—lung cancer	0.000554	0.00636	CbGeAlD
Dipyridamole—ABCC5—bone marrow—lung cancer	0.000514	0.0059	CbGeAlD
Dipyridamole—PDE8A—lymph node—lung cancer	0.00051	0.00586	CbGeAlD
Dipyridamole—PDE5A—lung—lung cancer	0.000509	0.00584	CbGeAlD
Dipyridamole—ABCC4—bronchus—lung cancer	0.0005	0.00574	CbGeAlD
Dipyridamole—PDE3A—lung—lung cancer	0.000495	0.00568	CbGeAlD
Dipyridamole—PDE1A—lymph node—lung cancer	0.000494	0.00567	CbGeAlD
Dipyridamole—SLC29A1—bone marrow—lung cancer	0.000472	0.00541	CbGeAlD
Dipyridamole—ABCC5—lung—lung cancer	0.000465	0.00534	CbGeAlD
Dipyridamole—SLC29A1—lung—lung cancer	0.000427	0.00491	CbGeAlD
Dipyridamole—ADA—lymph node—lung cancer	0.00042	0.00482	CbGeAlD
Dipyridamole—PDE4A—lymph node—lung cancer	0.000409	0.0047	CbGeAlD
Dipyridamole—ABCC4—bone marrow—lung cancer	0.000356	0.00409	CbGeAlD
Dipyridamole—PDE5A—lymph node—lung cancer	0.000348	0.004	CbGeAlD
Dipyridamole—PDE3A—lymph node—lung cancer	0.000339	0.00389	CbGeAlD
Dipyridamole—ABCC4—lung—lung cancer	0.000323	0.0037	CbGeAlD
Dipyridamole—ABCC5—lymph node—lung cancer	0.000318	0.00365	CbGeAlD
Dipyridamole—SLC29A1—lymph node—lung cancer	0.000292	0.00336	CbGeAlD
Dipyridamole—ABCC4—lymph node—lung cancer	0.000221	0.00253	CbGeAlD
Dipyridamole—ABCB1—respiratory system—lung cancer	0.000211	0.00243	CbGeAlD
Dipyridamole—ABCB1—epithelium—lung cancer	0.000177	0.00203	CbGeAlD
Dipyridamole—ABCB1—trachea—lung cancer	0.000156	0.00179	CbGeAlD
Dipyridamole—ABCB1—bone marrow—lung cancer	0.000124	0.00142	CbGeAlD
Dipyridamole—ABCB1—lung—lung cancer	0.000112	0.00129	CbGeAlD
Dipyridamole—Dizziness—Vinorelbine—lung cancer	9.38e-05	0.000601	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Doxorubicin—lung cancer	9.38e-05	0.000601	CcSEcCtD
Dipyridamole—Abdominal pain upper—Doxorubicin—lung cancer	9.38e-05	0.000601	CcSEcCtD
Dipyridamole—Nervous system disorder—Paclitaxel—lung cancer	9.36e-05	0.000599	CcSEcCtD
Dipyridamole—Thrombocytopenia—Paclitaxel—lung cancer	9.34e-05	0.000599	CcSEcCtD
Dipyridamole—Tachycardia—Paclitaxel—lung cancer	9.31e-05	0.000597	CcSEcCtD
Dipyridamole—Skin disorder—Paclitaxel—lung cancer	9.27e-05	0.000594	CcSEcCtD
Dipyridamole—Abdominal pain—Irinotecan—lung cancer	9.25e-05	0.000593	CcSEcCtD
Dipyridamole—Hyperhidrosis—Paclitaxel—lung cancer	9.23e-05	0.000591	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Cisplatin—lung cancer	9.17e-05	0.000588	CcSEcCtD
Dipyridamole—Anaemia—Docetaxel—lung cancer	9.16e-05	0.000587	CcSEcCtD
Dipyridamole—Hypotension—Etoposide—lung cancer	9.09e-05	0.000583	CcSEcCtD
Dipyridamole—Pain—Cisplatin—lung cancer	9.08e-05	0.000582	CcSEcCtD
Dipyridamole—Vomiting—Vinorelbine—lung cancer	9.02e-05	0.000578	CcSEcCtD
Dipyridamole—Rash—Vinorelbine—lung cancer	8.95e-05	0.000573	CcSEcCtD
Dipyridamole—Dermatitis—Vinorelbine—lung cancer	8.94e-05	0.000573	CcSEcCtD
Dipyridamole—Hypotension—Paclitaxel—lung cancer	8.92e-05	0.000571	CcSEcCtD
Dipyridamole—Headache—Vinorelbine—lung cancer	8.89e-05	0.000569	CcSEcCtD
Dipyridamole—Syncope—Docetaxel—lung cancer	8.89e-05	0.000569	CcSEcCtD
Dipyridamole—Dysphagia—Doxorubicin—lung cancer	8.88e-05	0.000569	CcSEcCtD
Dipyridamole—Palpitations—Docetaxel—lung cancer	8.76e-05	0.000561	CcSEcCtD
Dipyridamole—Feeling abnormal—Cisplatin—lung cancer	8.75e-05	0.000561	CcSEcCtD
Dipyridamole—Paraesthesia—Etoposide—lung cancer	8.74e-05	0.00056	CcSEcCtD
Dipyridamole—Loss of consciousness—Docetaxel—lung cancer	8.71e-05	0.000558	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Paclitaxel—lung cancer	8.69e-05	0.000557	CcSEcCtD
Dipyridamole—Dyspnoea—Etoposide—lung cancer	8.68e-05	0.000556	CcSEcCtD
Dipyridamole—Somnolence—Etoposide—lung cancer	8.65e-05	0.000554	CcSEcCtD
Dipyridamole—Cough—Docetaxel—lung cancer	8.65e-05	0.000554	CcSEcCtD
Dipyridamole—Angina pectoris—Doxorubicin—lung cancer	8.65e-05	0.000554	CcSEcCtD
Dipyridamole—Hypersensitivity—Irinotecan—lung cancer	8.62e-05	0.000552	CcSEcCtD
Dipyridamole—Convulsion—Docetaxel—lung cancer	8.59e-05	0.00055	CcSEcCtD
Dipyridamole—Paraesthesia—Paclitaxel—lung cancer	8.57e-05	0.000549	CcSEcCtD
Dipyridamole—Hypertension—Docetaxel—lung cancer	8.56e-05	0.000548	CcSEcCtD
Dipyridamole—Dyspnoea—Paclitaxel—lung cancer	8.51e-05	0.000545	CcSEcCtD
Dipyridamole—Somnolence—Paclitaxel—lung cancer	8.48e-05	0.000543	CcSEcCtD
Dipyridamole—Chest pain—Docetaxel—lung cancer	8.44e-05	0.000541	CcSEcCtD
Dipyridamole—Arthralgia—Docetaxel—lung cancer	8.44e-05	0.000541	CcSEcCtD
Dipyridamole—Myalgia—Docetaxel—lung cancer	8.44e-05	0.000541	CcSEcCtD
Dipyridamole—Nausea—Vinorelbine—lung cancer	8.43e-05	0.00054	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Etoposide—lung cancer	8.4e-05	0.000538	CcSEcCtD
Dipyridamole—Dyspepsia—Paclitaxel—lung cancer	8.4e-05	0.000538	CcSEcCtD
Dipyridamole—Asthenia—Irinotecan—lung cancer	8.4e-05	0.000538	CcSEcCtD
Dipyridamole—Fatigue—Etoposide—lung cancer	8.39e-05	0.000538	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	8.38e-05	0.000537	CcSEcCtD
Dipyridamole—Pain—Etoposide—lung cancer	8.32e-05	0.000533	CcSEcCtD
Dipyridamole—Dry mouth—Docetaxel—lung cancer	8.25e-05	0.000529	CcSEcCtD
Dipyridamole—Haemoglobin—Methotrexate—lung cancer	8.25e-05	0.000528	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Paclitaxel—lung cancer	8.24e-05	0.000528	CcSEcCtD
Dipyridamole—Fatigue—Paclitaxel—lung cancer	8.23e-05	0.000527	CcSEcCtD
Dipyridamole—Haemorrhage—Methotrexate—lung cancer	8.21e-05	0.000526	CcSEcCtD
Dipyridamole—Hepatitis—Methotrexate—lung cancer	8.21e-05	0.000526	CcSEcCtD
Dipyridamole—Asthenia—Gemcitabine—lung cancer	8.18e-05	0.000524	CcSEcCtD
Dipyridamole—Pain—Paclitaxel—lung cancer	8.16e-05	0.000523	CcSEcCtD
Dipyridamole—Pharyngitis—Methotrexate—lung cancer	8.14e-05	0.000522	CcSEcCtD
Dipyridamole—Oedema—Docetaxel—lung cancer	8.09e-05	0.000518	CcSEcCtD
Dipyridamole—Anaphylactic shock—Docetaxel—lung cancer	8.09e-05	0.000518	CcSEcCtD
Dipyridamole—Pruritus—Gemcitabine—lung cancer	8.06e-05	0.000517	CcSEcCtD
Dipyridamole—Feeling abnormal—Etoposide—lung cancer	8.02e-05	0.000514	CcSEcCtD
Dipyridamole—Diarrhoea—Irinotecan—lung cancer	8.01e-05	0.000513	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Etoposide—lung cancer	7.96e-05	0.00051	CcSEcCtD
Dipyridamole—Shock—Docetaxel—lung cancer	7.96e-05	0.00051	CcSEcCtD
Dipyridamole—Nervous system disorder—Docetaxel—lung cancer	7.93e-05	0.000508	CcSEcCtD
Dipyridamole—Thrombocytopenia—Docetaxel—lung cancer	7.92e-05	0.000507	CcSEcCtD
Dipyridamole—Tachycardia—Docetaxel—lung cancer	7.89e-05	0.000506	CcSEcCtD
Dipyridamole—Feeling abnormal—Paclitaxel—lung cancer	7.86e-05	0.000504	CcSEcCtD
Dipyridamole—Skin disorder—Docetaxel—lung cancer	7.86e-05	0.000503	CcSEcCtD
Dipyridamole—Hypersensitivity—Cisplatin—lung cancer	7.83e-05	0.000501	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Paclitaxel—lung cancer	7.8e-05	0.0005	CcSEcCtD
Dipyridamole—Diarrhoea—Gemcitabine—lung cancer	7.8e-05	0.0005	CcSEcCtD
Dipyridamole—Dizziness—Irinotecan—lung cancer	7.74e-05	0.000496	CcSEcCtD
Dipyridamole—Urticaria—Etoposide—lung cancer	7.73e-05	0.000495	CcSEcCtD
Dipyridamole—Abdominal pain—Etoposide—lung cancer	7.69e-05	0.000493	CcSEcCtD
Dipyridamole—ABCB1—lymph node—lung cancer	7.68e-05	0.000882	CbGeAlD
Dipyridamole—Tinnitus—Methotrexate—lung cancer	7.65e-05	0.00049	CcSEcCtD
Dipyridamole—Asthenia—Cisplatin—lung cancer	7.62e-05	0.000488	CcSEcCtD
Dipyridamole—Cardiac disorder—Methotrexate—lung cancer	7.62e-05	0.000488	CcSEcCtD
Dipyridamole—Urticaria—Paclitaxel—lung cancer	7.58e-05	0.000486	CcSEcCtD
Dipyridamole—Hypotension—Docetaxel—lung cancer	7.56e-05	0.000484	CcSEcCtD
Dipyridamole—Abdominal pain—Paclitaxel—lung cancer	7.54e-05	0.000483	CcSEcCtD
Dipyridamole—Angiopathy—Methotrexate—lung cancer	7.44e-05	0.000477	CcSEcCtD
Dipyridamole—Vomiting—Irinotecan—lung cancer	7.44e-05	0.000477	CcSEcCtD
Dipyridamole—Immune system disorder—Methotrexate—lung cancer	7.41e-05	0.000475	CcSEcCtD
Dipyridamole—Mediastinal disorder—Methotrexate—lung cancer	7.4e-05	0.000474	CcSEcCtD
Dipyridamole—Rash—Irinotecan—lung cancer	7.38e-05	0.000473	CcSEcCtD
Dipyridamole—Dermatitis—Irinotecan—lung cancer	7.37e-05	0.000472	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Docetaxel—lung cancer	7.37e-05	0.000472	CcSEcCtD
Dipyridamole—Chills—Methotrexate—lung cancer	7.36e-05	0.000472	CcSEcCtD
Dipyridamole—Headache—Irinotecan—lung cancer	7.33e-05	0.00047	CcSEcCtD
Dipyridamole—Diarrhoea—Cisplatin—lung cancer	7.27e-05	0.000466	CcSEcCtD
Dipyridamole—Paraesthesia—Docetaxel—lung cancer	7.26e-05	0.000465	CcSEcCtD
Dipyridamole—Alopecia—Methotrexate—lung cancer	7.25e-05	0.000464	CcSEcCtD
Dipyridamole—Vomiting—Gemcitabine—lung cancer	7.25e-05	0.000464	CcSEcCtD
Dipyridamole—Bradycardia—Doxorubicin—lung cancer	7.23e-05	0.000463	CcSEcCtD
Dipyridamole—Dyspnoea—Docetaxel—lung cancer	7.21e-05	0.000462	CcSEcCtD
Dipyridamole—Somnolence—Docetaxel—lung cancer	7.19e-05	0.000461	CcSEcCtD
Dipyridamole—Rash—Gemcitabine—lung cancer	7.19e-05	0.00046	CcSEcCtD
Dipyridamole—Dermatitis—Gemcitabine—lung cancer	7.18e-05	0.00046	CcSEcCtD
Dipyridamole—Hypersensitivity—Etoposide—lung cancer	7.17e-05	0.000459	CcSEcCtD
Dipyridamole—Haemoglobin—Doxorubicin—lung cancer	7.14e-05	0.000457	CcSEcCtD
Dipyridamole—Headache—Gemcitabine—lung cancer	7.14e-05	0.000457	CcSEcCtD
Dipyridamole—Rhinitis—Doxorubicin—lung cancer	7.12e-05	0.000456	CcSEcCtD
Dipyridamole—Dyspepsia—Docetaxel—lung cancer	7.12e-05	0.000456	CcSEcCtD
Dipyridamole—Hepatitis—Doxorubicin—lung cancer	7.11e-05	0.000455	CcSEcCtD
Dipyridamole—Haemorrhage—Doxorubicin—lung cancer	7.11e-05	0.000455	CcSEcCtD
Dipyridamole—Hypoaesthesia—Doxorubicin—lung cancer	7.07e-05	0.000453	CcSEcCtD
Dipyridamole—Pharyngitis—Doxorubicin—lung cancer	7.05e-05	0.000452	CcSEcCtD
Dipyridamole—Hypersensitivity—Paclitaxel—lung cancer	7.03e-05	0.00045	CcSEcCtD
Dipyridamole—Dysgeusia—Methotrexate—lung cancer	7e-05	0.000448	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Docetaxel—lung cancer	6.98e-05	0.000447	CcSEcCtD
Dipyridamole—Asthenia—Etoposide—lung cancer	6.98e-05	0.000447	CcSEcCtD
Dipyridamole—Fatigue—Docetaxel—lung cancer	6.97e-05	0.000447	CcSEcCtD
Dipyridamole—Nausea—Irinotecan—lung cancer	6.95e-05	0.000445	CcSEcCtD
Dipyridamole—Pain—Docetaxel—lung cancer	6.92e-05	0.000443	CcSEcCtD
Dipyridamole—Back pain—Methotrexate—lung cancer	6.91e-05	0.000443	CcSEcCtD
Dipyridamole—Pruritus—Etoposide—lung cancer	6.89e-05	0.000441	CcSEcCtD
Dipyridamole—Asthenia—Paclitaxel—lung cancer	6.85e-05	0.000439	CcSEcCtD
Dipyridamole—Nausea—Gemcitabine—lung cancer	6.77e-05	0.000434	CcSEcCtD
Dipyridamole—Vomiting—Cisplatin—lung cancer	6.75e-05	0.000433	CcSEcCtD
Dipyridamole—Pruritus—Paclitaxel—lung cancer	6.75e-05	0.000432	CcSEcCtD
Dipyridamole—Rash—Cisplatin—lung cancer	6.7e-05	0.000429	CcSEcCtD
Dipyridamole—Dermatitis—Cisplatin—lung cancer	6.69e-05	0.000429	CcSEcCtD
Dipyridamole—Feeling abnormal—Docetaxel—lung cancer	6.67e-05	0.000427	CcSEcCtD
Dipyridamole—Diarrhoea—Etoposide—lung cancer	6.66e-05	0.000427	CcSEcCtD
Dipyridamole—Ill-defined disorder—Methotrexate—lung cancer	6.63e-05	0.000425	CcSEcCtD
Dipyridamole—Tinnitus—Doxorubicin—lung cancer	6.62e-05	0.000424	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Docetaxel—lung cancer	6.61e-05	0.000424	CcSEcCtD
Dipyridamole—Anaemia—Methotrexate—lung cancer	6.6e-05	0.000423	CcSEcCtD
Dipyridamole—Flushing—Doxorubicin—lung cancer	6.59e-05	0.000422	CcSEcCtD
Dipyridamole—Cardiac disorder—Doxorubicin—lung cancer	6.59e-05	0.000422	CcSEcCtD
Dipyridamole—Diarrhoea—Paclitaxel—lung cancer	6.53e-05	0.000418	CcSEcCtD
Dipyridamole—Angiopathy—Doxorubicin—lung cancer	6.45e-05	0.000413	CcSEcCtD
Dipyridamole—Malaise—Methotrexate—lung cancer	6.44e-05	0.000413	CcSEcCtD
Dipyridamole—Dizziness—Etoposide—lung cancer	6.44e-05	0.000412	CcSEcCtD
Dipyridamole—Immune system disorder—Doxorubicin—lung cancer	6.42e-05	0.000411	CcSEcCtD
Dipyridamole—Vertigo—Methotrexate—lung cancer	6.42e-05	0.000411	CcSEcCtD
Dipyridamole—Mediastinal disorder—Doxorubicin—lung cancer	6.4e-05	0.00041	CcSEcCtD
Dipyridamole—Abdominal pain—Docetaxel—lung cancer	6.39e-05	0.00041	CcSEcCtD
Dipyridamole—Chills—Doxorubicin—lung cancer	6.38e-05	0.000408	CcSEcCtD
Dipyridamole—Arrhythmia—Doxorubicin—lung cancer	6.35e-05	0.000407	CcSEcCtD
Dipyridamole—Dizziness—Paclitaxel—lung cancer	6.31e-05	0.000404	CcSEcCtD
Dipyridamole—Nausea—Cisplatin—lung cancer	6.31e-05	0.000404	CcSEcCtD
Dipyridamole—Alopecia—Doxorubicin—lung cancer	6.28e-05	0.000402	CcSEcCtD
Dipyridamole—Cough—Methotrexate—lung cancer	6.23e-05	0.000399	CcSEcCtD
Dipyridamole—Convulsion—Methotrexate—lung cancer	6.19e-05	0.000396	CcSEcCtD
Dipyridamole—Vomiting—Etoposide—lung cancer	6.19e-05	0.000396	CcSEcCtD
Dipyridamole—Rash—Etoposide—lung cancer	6.14e-05	0.000393	CcSEcCtD
Dipyridamole—Dermatitis—Etoposide—lung cancer	6.13e-05	0.000393	CcSEcCtD
Dipyridamole—Headache—Etoposide—lung cancer	6.1e-05	0.000391	CcSEcCtD
Dipyridamole—Flatulence—Doxorubicin—lung cancer	6.09e-05	0.00039	CcSEcCtD
Dipyridamole—Myalgia—Methotrexate—lung cancer	6.08e-05	0.00039	CcSEcCtD
Dipyridamole—Arthralgia—Methotrexate—lung cancer	6.08e-05	0.00039	CcSEcCtD
Dipyridamole—Chest pain—Methotrexate—lung cancer	6.08e-05	0.00039	CcSEcCtD
Dipyridamole—Tension—Doxorubicin—lung cancer	6.07e-05	0.000389	CcSEcCtD
Dipyridamole—Vomiting—Paclitaxel—lung cancer	6.07e-05	0.000389	CcSEcCtD
Dipyridamole—Dysgeusia—Doxorubicin—lung cancer	6.06e-05	0.000388	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.04e-05	0.000387	CcSEcCtD
Dipyridamole—Rash—Paclitaxel—lung cancer	6.02e-05	0.000385	CcSEcCtD
Dipyridamole—Dermatitis—Paclitaxel—lung cancer	6.01e-05	0.000385	CcSEcCtD
Dipyridamole—Discomfort—Methotrexate—lung cancer	6.01e-05	0.000385	CcSEcCtD
Dipyridamole—Nervousness—Doxorubicin—lung cancer	6.01e-05	0.000385	CcSEcCtD
Dipyridamole—Back pain—Doxorubicin—lung cancer	5.98e-05	0.000383	CcSEcCtD
Dipyridamole—Headache—Paclitaxel—lung cancer	5.98e-05	0.000383	CcSEcCtD
Dipyridamole—Hypersensitivity—Docetaxel—lung cancer	5.96e-05	0.000382	CcSEcCtD
Dipyridamole—Muscle spasms—Doxorubicin—lung cancer	5.95e-05	0.000381	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methotrexate—lung cancer	5.83e-05	0.000373	CcSEcCtD
Dipyridamole—Asthenia—Docetaxel—lung cancer	5.8e-05	0.000372	CcSEcCtD
Dipyridamole—Nausea—Etoposide—lung cancer	5.78e-05	0.00037	CcSEcCtD
Dipyridamole—Ill-defined disorder—Doxorubicin—lung cancer	5.74e-05	0.000368	CcSEcCtD
Dipyridamole—Pruritus—Docetaxel—lung cancer	5.72e-05	0.000367	CcSEcCtD
Dipyridamole—Nervous system disorder—Methotrexate—lung cancer	5.72e-05	0.000366	CcSEcCtD
Dipyridamole—Anaemia—Doxorubicin—lung cancer	5.72e-05	0.000366	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methotrexate—lung cancer	5.71e-05	0.000366	CcSEcCtD
Dipyridamole—Nausea—Paclitaxel—lung cancer	5.67e-05	0.000363	CcSEcCtD
Dipyridamole—Skin disorder—Methotrexate—lung cancer	5.66e-05	0.000363	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methotrexate—lung cancer	5.64e-05	0.000361	CcSEcCtD
Dipyridamole—Malaise—Doxorubicin—lung cancer	5.58e-05	0.000357	CcSEcCtD
Dipyridamole—Vertigo—Doxorubicin—lung cancer	5.56e-05	0.000356	CcSEcCtD
Dipyridamole—Syncope—Doxorubicin—lung cancer	5.55e-05	0.000355	CcSEcCtD
Dipyridamole—Diarrhoea—Docetaxel—lung cancer	5.53e-05	0.000355	CcSEcCtD
Dipyridamole—Palpitations—Doxorubicin—lung cancer	5.47e-05	0.00035	CcSEcCtD
Dipyridamole—Hypotension—Methotrexate—lung cancer	5.45e-05	0.000349	CcSEcCtD
Dipyridamole—Loss of consciousness—Doxorubicin—lung cancer	5.44e-05	0.000348	CcSEcCtD
Dipyridamole—Cough—Doxorubicin—lung cancer	5.4e-05	0.000346	CcSEcCtD
Dipyridamole—Convulsion—Doxorubicin—lung cancer	5.36e-05	0.000343	CcSEcCtD
Dipyridamole—Dizziness—Docetaxel—lung cancer	5.35e-05	0.000343	CcSEcCtD
Dipyridamole—Hypertension—Doxorubicin—lung cancer	5.34e-05	0.000342	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methotrexate—lung cancer	5.31e-05	0.00034	CcSEcCtD
Dipyridamole—Arthralgia—Doxorubicin—lung cancer	5.27e-05	0.000337	CcSEcCtD
Dipyridamole—Myalgia—Doxorubicin—lung cancer	5.27e-05	0.000337	CcSEcCtD
Dipyridamole—Chest pain—Doxorubicin—lung cancer	5.27e-05	0.000337	CcSEcCtD
Dipyridamole—Anxiety—Doxorubicin—lung cancer	5.25e-05	0.000336	CcSEcCtD
Dipyridamole—Paraesthesia—Methotrexate—lung cancer	5.23e-05	0.000335	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.23e-05	0.000335	CcSEcCtD
Dipyridamole—Discomfort—Doxorubicin—lung cancer	5.2e-05	0.000333	CcSEcCtD
Dipyridamole—Dyspnoea—Methotrexate—lung cancer	5.2e-05	0.000333	CcSEcCtD
Dipyridamole—Somnolence—Methotrexate—lung cancer	5.18e-05	0.000332	CcSEcCtD
Dipyridamole—Dry mouth—Doxorubicin—lung cancer	5.15e-05	0.00033	CcSEcCtD
Dipyridamole—Vomiting—Docetaxel—lung cancer	5.14e-05	0.000329	CcSEcCtD
Dipyridamole—Dyspepsia—Methotrexate—lung cancer	5.13e-05	0.000329	CcSEcCtD
Dipyridamole—Rash—Docetaxel—lung cancer	5.1e-05	0.000327	CcSEcCtD
Dipyridamole—Dermatitis—Docetaxel—lung cancer	5.1e-05	0.000326	CcSEcCtD
Dipyridamole—Headache—Docetaxel—lung cancer	5.07e-05	0.000325	CcSEcCtD
Dipyridamole—Oedema—Doxorubicin—lung cancer	5.05e-05	0.000323	CcSEcCtD
Dipyridamole—Anaphylactic shock—Doxorubicin—lung cancer	5.05e-05	0.000323	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Methotrexate—lung cancer	5.03e-05	0.000322	CcSEcCtD
Dipyridamole—Fatigue—Methotrexate—lung cancer	5.03e-05	0.000322	CcSEcCtD
Dipyridamole—Pain—Methotrexate—lung cancer	4.99e-05	0.000319	CcSEcCtD
Dipyridamole—Shock—Doxorubicin—lung cancer	4.97e-05	0.000318	CcSEcCtD
Dipyridamole—Nervous system disorder—Doxorubicin—lung cancer	4.95e-05	0.000317	CcSEcCtD
Dipyridamole—Thrombocytopenia—Doxorubicin—lung cancer	4.94e-05	0.000317	CcSEcCtD
Dipyridamole—Tachycardia—Doxorubicin—lung cancer	4.93e-05	0.000316	CcSEcCtD
Dipyridamole—Skin disorder—Doxorubicin—lung cancer	4.9e-05	0.000314	CcSEcCtD
Dipyridamole—Hyperhidrosis—Doxorubicin—lung cancer	4.88e-05	0.000313	CcSEcCtD
Dipyridamole—Nausea—Docetaxel—lung cancer	4.8e-05	0.000308	CcSEcCtD
Dipyridamole—Feeling abnormal—Methotrexate—lung cancer	4.8e-05	0.000308	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methotrexate—lung cancer	4.77e-05	0.000305	CcSEcCtD
Dipyridamole—Hypotension—Doxorubicin—lung cancer	4.72e-05	0.000302	CcSEcCtD
Dipyridamole—Urticaria—Methotrexate—lung cancer	4.63e-05	0.000297	CcSEcCtD
Dipyridamole—Abdominal pain—Methotrexate—lung cancer	4.61e-05	0.000295	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.6e-05	0.000295	CcSEcCtD
Dipyridamole—Paraesthesia—Doxorubicin—lung cancer	4.53e-05	0.00029	CcSEcCtD
Dipyridamole—Dyspnoea—Doxorubicin—lung cancer	4.5e-05	0.000288	CcSEcCtD
Dipyridamole—Somnolence—Doxorubicin—lung cancer	4.49e-05	0.000287	CcSEcCtD
Dipyridamole—Dyspepsia—Doxorubicin—lung cancer	4.44e-05	0.000285	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Doxorubicin—lung cancer	4.36e-05	0.000279	CcSEcCtD
Dipyridamole—Fatigue—Doxorubicin—lung cancer	4.35e-05	0.000279	CcSEcCtD
Dipyridamole—Pain—Doxorubicin—lung cancer	4.32e-05	0.000277	CcSEcCtD
Dipyridamole—Hypersensitivity—Methotrexate—lung cancer	4.3e-05	0.000275	CcSEcCtD
Dipyridamole—Asthenia—Methotrexate—lung cancer	4.18e-05	0.000268	CcSEcCtD
Dipyridamole—Feeling abnormal—Doxorubicin—lung cancer	4.16e-05	0.000266	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Doxorubicin—lung cancer	4.13e-05	0.000264	CcSEcCtD
Dipyridamole—Pruritus—Methotrexate—lung cancer	4.12e-05	0.000264	CcSEcCtD
Dipyridamole—Urticaria—Doxorubicin—lung cancer	4.01e-05	0.000257	CcSEcCtD
Dipyridamole—Abdominal pain—Doxorubicin—lung cancer	3.99e-05	0.000256	CcSEcCtD
Dipyridamole—Diarrhoea—Methotrexate—lung cancer	3.99e-05	0.000256	CcSEcCtD
Dipyridamole—Dizziness—Methotrexate—lung cancer	3.86e-05	0.000247	CcSEcCtD
Dipyridamole—Hypersensitivity—Doxorubicin—lung cancer	3.72e-05	0.000238	CcSEcCtD
Dipyridamole—Vomiting—Methotrexate—lung cancer	3.71e-05	0.000237	CcSEcCtD
Dipyridamole—Rash—Methotrexate—lung cancer	3.68e-05	0.000235	CcSEcCtD
Dipyridamole—Dermatitis—Methotrexate—lung cancer	3.67e-05	0.000235	CcSEcCtD
Dipyridamole—Headache—Methotrexate—lung cancer	3.65e-05	0.000234	CcSEcCtD
Dipyridamole—Asthenia—Doxorubicin—lung cancer	3.62e-05	0.000232	CcSEcCtD
Dipyridamole—Pruritus—Doxorubicin—lung cancer	3.57e-05	0.000229	CcSEcCtD
Dipyridamole—Nausea—Methotrexate—lung cancer	3.46e-05	0.000222	CcSEcCtD
Dipyridamole—Diarrhoea—Doxorubicin—lung cancer	3.45e-05	0.000221	CcSEcCtD
Dipyridamole—Dizziness—Doxorubicin—lung cancer	3.34e-05	0.000214	CcSEcCtD
Dipyridamole—Vomiting—Doxorubicin—lung cancer	3.21e-05	0.000206	CcSEcCtD
Dipyridamole—Rash—Doxorubicin—lung cancer	3.18e-05	0.000204	CcSEcCtD
Dipyridamole—Dermatitis—Doxorubicin—lung cancer	3.18e-05	0.000204	CcSEcCtD
Dipyridamole—Headache—Doxorubicin—lung cancer	3.16e-05	0.000203	CcSEcCtD
Dipyridamole—Nausea—Doxorubicin—lung cancer	3e-05	0.000192	CcSEcCtD
Dipyridamole—PDE3A—Signaling Pathways—RAF1—lung cancer	4.03e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—lung cancer	4.03e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—lung cancer	4.02e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—AKT1—lung cancer	4.02e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—AKT1—lung cancer	4.01e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ERBB2—lung cancer	3.99e-06	2.41e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	3.99e-06	2.4e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EP300—lung cancer	3.99e-06	2.4e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CASP3—lung cancer	3.98e-06	2.4e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2—lung cancer	3.97e-06	2.39e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—lung cancer	3.95e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—lung cancer	3.94e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CB—lung cancer	3.94e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MTOR—lung cancer	3.94e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GNG11—lung cancer	3.93e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—HRAS—lung cancer	3.92e-06	2.36e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAP2K1—lung cancer	3.91e-06	2.36e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MAPK3—lung cancer	3.9e-06	2.35e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MAPK3—lung cancer	3.9e-06	2.35e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCL8—lung cancer	3.89e-06	2.35e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CD—lung cancer	3.89e-06	2.34e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—SRC—lung cancer	3.88e-06	2.34e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCND1—lung cancer	3.87e-06	2.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MAPK3—lung cancer	3.87e-06	2.33e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—HRAS—lung cancer	3.87e-06	2.33e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—HRAS—lung cancer	3.87e-06	2.33e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—JUN—lung cancer	3.86e-06	2.33e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	3.86e-06	2.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—PIK3CA—lung cancer	3.85e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTEN—lung cancer	3.83e-06	2.31e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PIK3CA—lung cancer	3.82e-06	2.3e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MDM2—lung cancer	3.81e-06	2.29e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—KRAS—lung cancer	3.8e-06	2.29e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—KRAS—lung cancer	3.8e-06	2.29e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MYC—lung cancer	3.8e-06	2.29e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MYC—lung cancer	3.8e-06	2.29e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RAF1—lung cancer	3.79e-06	2.29e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL8—lung cancer	3.78e-06	2.28e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—AKT1—lung cancer	3.77e-06	2.27e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—HRAS—lung cancer	3.77e-06	2.27e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—HRAS—lung cancer	3.76e-06	2.27e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—lung cancer	3.76e-06	2.27e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AKT1—lung cancer	3.76e-06	2.27e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ERBB2—lung cancer	3.75e-06	2.26e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—lung cancer	3.75e-06	2.26e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CDKN1A—lung cancer	3.74e-06	2.26e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALDOA—lung cancer	3.74e-06	2.25e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—STAT3—lung cancer	3.74e-06	2.25e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PTEN—lung cancer	3.74e-06	2.25e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AKT1—lung cancer	3.73e-06	2.25e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AKT1—lung cancer	3.73e-06	2.25e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NRAS—lung cancer	3.73e-06	2.25e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CASP3—lung cancer	3.72e-06	2.24e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2—lung cancer	3.72e-06	2.24e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PIK3CA—lung cancer	3.72e-06	2.24e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	3.71e-06	2.24e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—lung cancer	3.71e-06	2.24e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—lung cancer	3.71e-06	2.24e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MTOR—lung cancer	3.7e-06	2.23e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CB—lung cancer	3.7e-06	2.23e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—lung cancer	3.7e-06	2.23e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—lung cancer	3.7e-06	2.23e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—lung cancer	3.68e-06	2.22e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AKT1—lung cancer	3.66e-06	2.2e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—EP300—lung cancer	3.65e-06	2.2e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AKT1—lung cancer	3.65e-06	2.2e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NCOA3—lung cancer	3.63e-06	2.19e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCND1—lung cancer	3.62e-06	2.18e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CASP3—lung cancer	3.62e-06	2.18e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—JUN—lung cancer	3.62e-06	2.18e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2—lung cancer	3.62e-06	2.18e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—lung cancer	3.61e-06	2.17e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—lung cancer	3.6e-06	2.17e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MAPK3—lung cancer	3.57e-06	2.15e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EP300—lung cancer	3.56e-06	2.15e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL8—lung cancer	3.56e-06	2.14e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—HRAS—lung cancer	3.54e-06	2.13e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ADCY1—lung cancer	3.53e-06	2.13e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ABCG2—lung cancer	3.53e-06	2.13e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCND1—lung cancer	3.53e-06	2.13e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—lung cancer	3.52e-06	2.12e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—JUN—lung cancer	3.52e-06	2.12e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—KRAS—lung cancer	3.51e-06	2.11e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—KRAS—lung cancer	3.51e-06	2.11e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CDKN1A—lung cancer	3.51e-06	2.11e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PTEN—lung cancer	3.5e-06	2.11e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PIK3CA—lung cancer	3.49e-06	2.11e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PIK3CA—lung cancer	3.49e-06	2.1e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MDM2—lung cancer	3.48e-06	2.1e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—KRAS—lung cancer	3.48e-06	2.1e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MYC—lung cancer	3.47e-06	2.09e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RAF1—lung cancer	3.47e-06	2.09e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SRC—lung cancer	3.47e-06	2.09e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ENO2—lung cancer	3.46e-06	2.09e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HPGDS—lung cancer	3.46e-06	2.09e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AKT1—lung cancer	3.46e-06	2.09e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPP2R1B—lung cancer	3.44e-06	2.07e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AKT1—lung cancer	3.44e-06	2.07e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ERBB2—lung cancer	3.43e-06	2.07e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—lung cancer	3.42e-06	2.06e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AKT1—lung cancer	3.41e-06	2.06e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AKT1—lung cancer	3.41e-06	2.06e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CDKN1A—lung cancer	3.41e-06	2.06e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CASP3—lung cancer	3.41e-06	2.05e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PTEN—lung cancer	3.4e-06	2.05e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2—lung cancer	3.4e-06	2.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—lung cancer	3.4e-06	2.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MTOR—lung cancer	3.39e-06	2.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CB—lung cancer	3.39e-06	2.04e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—lung cancer	3.38e-06	2.04e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—lung cancer	3.37e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTT1—lung cancer	3.36e-06	2.02e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—STAT3—lung cancer	3.34e-06	2.01e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EP300—lung cancer	3.34e-06	2.01e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NRAS—lung cancer	3.33e-06	2.01e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AKT1—lung cancer	3.33e-06	2.01e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AKT1—lung cancer	3.32e-06	2e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GCLC—lung cancer	3.32e-06	2e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP2A6—lung cancer	3.32e-06	2e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCND1—lung cancer	3.31e-06	2e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—JUN—lung cancer	3.31e-06	1.99e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	3.26e-06	1.96e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL8—lung cancer	3.25e-06	1.96e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EP300—lung cancer	3.25e-06	1.96e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SRC—lung cancer	3.24e-06	1.96e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—HRAS—lung cancer	3.23e-06	1.95e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HRAS—lung cancer	3.23e-06	1.95e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PIK3CA—lung cancer	3.22e-06	1.94e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PIK3CA—lung cancer	3.22e-06	1.94e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—lung cancer	3.22e-06	1.94e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—KRAS—lung cancer	3.21e-06	1.93e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CDKN1A—lung cancer	3.21e-06	1.93e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PTEN—lung cancer	3.2e-06	1.93e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PIK3CA—lung cancer	3.19e-06	1.92e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MAPK3—lung cancer	3.19e-06	1.92e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—lung cancer	3.16e-06	1.9e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SRC—lung cancer	3.16e-06	1.9e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ENO1—lung cancer	3.15e-06	1.9e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	3.14e-06	1.9e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AKT1—lung cancer	3.14e-06	1.9e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—STAT3—lung cancer	3.13e-06	1.89e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AKT1—lung cancer	3.12e-06	1.88e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NRAS—lung cancer	3.12e-06	1.88e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CASP3—lung cancer	3.11e-06	1.88e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2—lung cancer	3.11e-06	1.87e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MYC—lung cancer	3.11e-06	1.87e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—lung cancer	3.09e-06	1.87e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—lung cancer	3.09e-06	1.86e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—lung cancer	3.07e-06	1.85e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EP300—lung cancer	3.05e-06	1.84e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—STAT3—lung cancer	3.04e-06	1.83e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—lung cancer	3.04e-06	1.83e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NRAS—lung cancer	3.04e-06	1.83e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AKT1—lung cancer	3.04e-06	1.83e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCND1—lung cancer	3.03e-06	1.83e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—JUN—lung cancer	3.03e-06	1.82e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MAPK3—lung cancer	2.99e-06	1.8e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HRAS—lung cancer	2.98e-06	1.8e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HRAS—lung cancer	2.98e-06	1.8e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SRC—lung cancer	2.97e-06	1.79e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HRAS—lung cancer	2.95e-06	1.78e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PIK3CA—lung cancer	2.95e-06	1.78e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—lung cancer	2.94e-06	1.77e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	2.94e-06	1.77e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CDKN1A—lung cancer	2.93e-06	1.77e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PTEN—lung cancer	2.93e-06	1.76e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MAPK3—lung cancer	2.91e-06	1.75e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MYC—lung cancer	2.91e-06	1.75e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—lung cancer	2.89e-06	1.74e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KRAS—lung cancer	2.87e-06	1.73e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—STAT3—lung cancer	2.86e-06	1.72e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AKT1—lung cancer	2.85e-06	1.72e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NRAS—lung cancer	2.85e-06	1.72e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—lung cancer	2.85e-06	1.72e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—lung cancer	2.85e-06	1.72e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—AKT1—lung cancer	2.85e-06	1.72e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—lung cancer	2.84e-06	1.71e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MYC—lung cancer	2.83e-06	1.7e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—lung cancer	2.83e-06	1.7e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP2E1—lung cancer	2.82e-06	1.7e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EP300—lung cancer	2.79e-06	1.68e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NQO1—lung cancer	2.79e-06	1.68e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—lung cancer	2.77e-06	1.67e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MAPK3—lung cancer	2.73e-06	1.65e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HRAS—lung cancer	2.73e-06	1.64e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SRC—lung cancer	2.71e-06	1.64e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PIK3CA—lung cancer	2.7e-06	1.63e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KRAS—lung cancer	2.69e-06	1.62e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	2.66e-06	1.6e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MYC—lung cancer	2.66e-06	1.6e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—lung cancer	2.64e-06	1.59e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3CA—lung cancer	2.64e-06	1.59e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—AKT1—lung cancer	2.63e-06	1.59e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—AKT1—lung cancer	2.63e-06	1.59e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—STAT3—lung cancer	2.62e-06	1.58e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KRAS—lung cancer	2.61e-06	1.58e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NRAS—lung cancer	2.61e-06	1.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—lung cancer	2.61e-06	1.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AKT1—lung cancer	2.61e-06	1.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—lung cancer	2.6e-06	1.57e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—lung cancer	2.55e-06	1.54e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—STK11—lung cancer	2.52e-06	1.52e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAPK3—lung cancer	2.5e-06	1.51e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CA—lung cancer	2.47e-06	1.49e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KRAS—lung cancer	2.46e-06	1.48e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HRAS—lung cancer	2.44e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MYC—lung cancer	2.43e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—AKT1—lung cancer	2.41e-06	1.45e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CA—lung cancer	2.4e-06	1.45e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—lung cancer	2.39e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—lung cancer	2.38e-06	1.43e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—lung cancer	2.33e-06	1.41e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTP1—lung cancer	2.33e-06	1.4e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—lung cancer	2.32e-06	1.4e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HRAS—lung cancer	2.28e-06	1.38e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CAT—lung cancer	2.26e-06	1.37e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CA—lung cancer	2.26e-06	1.36e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KRAS—lung cancer	2.25e-06	1.35e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HRAS—lung cancer	2.22e-06	1.34e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AKT1—lung cancer	2.21e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—lung cancer	2.19e-06	1.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—lung cancer	2.18e-06	1.32e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TYMS—lung cancer	2.16e-06	1.3e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT1—lung cancer	2.15e-06	1.3e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTM1—lung cancer	2.14e-06	1.29e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—lung cancer	2.13e-06	1.28e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HRAS—lung cancer	2.09e-06	1.26e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CA—lung cancer	2.06e-06	1.24e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP1A1—lung cancer	2.03e-06	1.22e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT1—lung cancer	2.02e-06	1.22e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ERCC2—lung cancer	2.01e-06	1.21e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—lung cancer	2e-06	1.2e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—lung cancer	2e-06	1.2e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT1—lung cancer	1.96e-06	1.18e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HRAS—lung cancer	1.91e-06	1.15e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT1—lung cancer	1.84e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—lung cancer	1.83e-06	1.1e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOA1—lung cancer	1.74e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT1—lung cancer	1.69e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CG—lung cancer	1.59e-06	9.57e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—POMC—lung cancer	1.51e-06	9.11e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CREBBP—lung cancer	1.47e-06	8.88e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CD—lung cancer	1.4e-06	8.42e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—lung cancer	1.38e-06	8.31e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CB—lung cancer	1.22e-06	7.34e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—lung cancer	1.21e-06	7.27e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTEN—lung cancer	1.05e-06	6.34e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—EP300—lung cancer	1e-06	6.05e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CA—lung cancer	7.42e-07	4.47e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKT1—lung cancer	6.06e-07	3.65e-06	CbGpPWpGaD
